Compound ID | 239
BAS00127538
Class: Cell-wall synthesis inhibitor (lipid II inhibitor)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Defensin Mimetic. Acinetobacter baumannii, with future possibility as a broad spectrum antibiotic. |
| Propensity to select resistant mutants: | Yes |
| Description: | di-phenyl-tri-methyl indolene pyrylium |
| Institute where first reported: | University of Maryland Sch. Of Pharmacy, Baltimore, USA |
| Year first mentioned: | 2013 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.